Head and Neck Squamous Cell Carcinoma (HNSCC) Latest Advances
Find the Latest Research About Head and Neck Squamous Cell Carcinoma (HNSCC)
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24299 publications
Efficacy of first-line immune checkpoint inhibitors for recurrent/metastatic head and neck cancer: a systematic review and meta-analysis.
Journal: Immunotherapy
Published: April 14, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer.
Journal: Science immunology
Published: April 10, 2026
Correlation of E-cadherin, vimentin, CD206, programmed cell death receptor 1, and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma.
Journal: The Journal of international medical research
Published: April 09, 2026
The Prognostic Value of SERPINE1 in Clinical Outcomes in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Technology in cancer research & treatment
Published: April 03, 2026
Transcriptomic atlas of premalignant oral squamous cell carcinoma in an aging mouse model reveals an enhanced immune response and dysregulation of head and neck tissue stem cells.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.
Journal: JAMA otolaryngology-- head & neck surgery
Published: April 02, 2026
Effect of Golgi membrane protein 1 on the proliferation, migration, and invasion of oral squamous cell carcinoma cells and its mechanism
Journal: Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
Published: March 31, 2026
BPI26-017: Feasibility and Early Clinical Outcomes of Hypofractionated Concurrent Chemoradiation (55 Gy in 20 Fractions) for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Prospective Institutional Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
Correlations between regulatory T cells and the tumor immune microenvironment in head and neck squamous cell carcinoma
Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: March 31, 2026
HSR26-229: Efficacy and Safety of Immune Checkpoint Inhibitors Compared to Chemotherapy and Radiotherapy Alone in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Reconstructed Time-to-Event Data from Randomized Controlled Trials.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 26, 2026
Last Updated: 04/28/2026